These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1224931)

  • 1. [Induction of chromosome aberrations by antirheumatic therapy].
    Vormittag W
    Acta Med Austriaca; 1975; 2(4):148-53. PubMed ID: 1224931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytostatic immunosuppressive therapy, chromosomal aberrations and carcinogenic effect (author's transl)].
    Vormittag W
    Wien Klin Wochenschr; 1974 Feb; 86(3):69-75. PubMed ID: 4439938
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive therapy chronic polyarthritis].
    Thumb N
    Wien Z Inn Med; 1972 Dec; ():Suppl:1-52. PubMed ID: 4574028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytogenetic investigations in patients receiving an intraarticular injection of gold-198 (author's transl)].
    Vormittag W; Kunze-Mühl E; Thumb N
    Wien Klin Wochenschr; 1976 Feb; 88(3):87-91. PubMed ID: 960709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy and mutagenesis. A study of chromosome aberrations as a test for mutagenesis after the use of cyclophosphamide, methotrexate and cytosine arabinoside].
    Stojimirović E; Ajdarić B; Korać D; Garzicić B
    Bilt Hematol Transfuz; 1979; 7(1 Suppl):27-37. PubMed ID: 553507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.
    Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B
    Br Med J; 1974 Sep; 3(5934):763-6. PubMed ID: 4606370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of chronic polyarthritis in the practice].
    Steiger U
    Schweiz Rundsch Med Prax; 1971 May; 60(20):631-3. PubMed ID: 4326005
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chromosomal aberrations in lymphocytes of patients with systemic lupus erythematosus during cytostatic therapy].
    Latipova NS; Aliavi AL
    Ter Arkh; 2002; 74(5):35-8. PubMed ID: 12087903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosomal aberrations in peripheral lymphocytes of patients with multiple sclerosis (author's transl)].
    Unglaub-Leisten I; Stickl H; Frick E; Angstwurm H; Ring J
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2028-34. PubMed ID: 1157719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents.
    Seidenfeld AM; Smythe HA; Ogryzlo MA; Urowitz MB; Dotten DA
    J Rheumatol; 1984 Oct; 11(5):586-7. PubMed ID: 6512790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive treatment in rheumatoid arthritis].
    Parrow A
    Nord Med; 1971 Jul; 86(27):835. PubMed ID: 5558475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of circulating anti-tissue antibodies and titer of rheumatoid factor in rheumatoid polyarthritis under the effect of immunosuppressive drugs, antimalarials and gold salts].
    Andreev T; Kozhukharova M; Pilosof T
    Vutr Boles; 1972; 11(3):125-8. PubMed ID: 4547886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive (cytostatic) drugs in rheumatology].
    Dixon AS
    Rev Esp Reum Enferm Osteoartic; 1972; 15(2):89-96. PubMed ID: 5033163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
    Wawrzyńska-Pagowska J; Graff-Wróblewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Scislowska M
    Z Rheumaforsch; 1973; 32(1):32-9. PubMed ID: 4693416
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous cyclophosphamide and methylprednisolone for the treatment of bronchiolitis obliterans and interstitial fibrosis associated with crysotherapy.
    Fort JG; Scovern H; Abruzzo JL
    J Rheumatol; 1988; 15(5):850-4. PubMed ID: 3172099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects in immunosuppressive therapy].
    Thumb N
    Acta Med Austriaca; 1975; 2(4):134-40. PubMed ID: 1243805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Trial of azathioprine, cyclophosphamide, and gold in rheumatoid arthritis.
    Woodland J; Mason RM; Harris J; Dixon AS; Currey HL; Brownjohn AM; Davies J; Owen-Smith BD
    Ann Rheum Dis; 1974 Jul; 33(4):399-401. PubMed ID: 4606944
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacology of antirheumatic drugs.
    Parnham MJ
    Agents Actions Suppl; 1984; 14():153-69. PubMed ID: 6382972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.